• Innoviz Technologies recently announced it was selected by a major commercial vehicle OEM to supply InnovizTwo LiDAR sensors for series production of SAE Level 4 autonomous class-8 semi-trucks across North America, beginning with initial units supporting data collection fleets this year and parallel software integration work.
• This move broadens Innoviz’s market reach beyond passenger vehicles, highlighting LiDAR’s rising adoption in commercial trucking and strengthening Innoviz’s role as a preferred supplier for advanced autonomous vehicle technologies.
• We'll examine how this significant OEM selection for commercial autonomous trucking could reshape Innoviz Technologies' investment narrative and outlook.

Explore 23 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

Innoviz Technologies Investment Narrative Recap

To own a piece of Innoviz Technologies, you have to believe in the accelerating adoption of LiDAR as a critical enabler for autonomous vehicles, with series production contracts as the key proof point. The recent commercial vehicle OEM win does move Innoviz closer to production-level revenues but does not fully resolve the near-term uncertainty around the conversion of development agreements to mass production, remaining the most important catalyst, as well as the biggest risk for the business right now.

The most relevant recent announcement is the July 8 news that Innoviz began shipping its InnovizTwo LiDAR units from Fabrinet's production line, signaling progress on scaling manufacturing for future series production programs. This manufacturing milestone ties in directly with Innoviz’s need to demonstrate capacity and reliability if it is to secure, and then sustain, high-volume OEM contracts and potentially improve revenue predictability.

However, against this progress, investors should keep in mind that lumpiness in revenue from non-recurring engineering payments could still affect cash flow and …

Innoviz Technologies' narrative projects $445.7 million revenue and $40.3 million earnings by 2028. This requires 127.8% yearly revenue growth and a $114.9 million increase in earnings from -$74.6 million today.

Uncover how Innoviz Technologies' forecasts yield a $2.93 fair value, a 70% upside to its current price.

Exploring Other Perspectives

Six individual fair value estimates from the Simply Wall St Community range from US$1.21 to US$3.73 per share. While opinions vary, the risk of development deals failing to convert into series production could impact how quickly Innoviz achieves revenue stability and future performance, so be sure to weigh several viewpoints.

Explore 6 other fair value estimates on Innoviz Technologies - why the stock might be worth 30% less than the current price!

Build Your Own Innoviz Technologies Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Innoviz Technologies research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Innoviz Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Innoviz Technologies' overall financial health at a glance.

Searching For A Fresh Perspective?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• Find companies with promising cash flow potential yet trading below their fair value.
• These 9 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.